Related NCI Initiatives
The National Cancer Institute has recognized that the achievement of 21st century personalized cancer care requires a commitment to a new kind of scientific enterprise. Such an enterprise is characterized by “team science” across multiple laboratories that share data in standardized formats; collaborations among academic, private, and public sector organizations; and high-throughput technology platforms supported by seamless informatics capability and systems-level planning and management. The technology initiatives launched through the NCI, including the Alliance for Nanotechnology in Cancer, are positioned to support this transformation in cancer research for better prevention, diagnosis, and treatment of cancer and improved outcomes for patients.
Learn about the offices within the NCI's Center for Strategic Scientific Initiatives by visiting each program website:
- Clinical Proteomic Technologies for Cancer (CPTC)
- Office of Biorepositories and Biospecimen Research (OBBR)
- Office of Cancer Genomics (OCG)
- Physical Sciences in Oncology (PSIO)
- The Cancer Genome Atlas (TCGA)
Learn about other complementary NCI initiatives:
